A comprehensive view of Injectables / Infusions / IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Par Pharmaceutical expands recall to include seven lots of Treprostinil Injection 20mg/20mL due to the possibility of silicone particulates in the product; affected product is distributed in 20mL multidose vials as sterile solutions in water for injection
Published: April 23, 2024 by PR Newswire
Eli Lilly to acquire FDA-approved manufacturing facility from Nexus Pharmaceuticals to expand its injectable product manufacturing and meet increased demands; production at the Pleasant Prairie, Wisconsin, facility projected to start by end of 2025
Published: April 22, 2024 by Eli Lilly & Co.
FDA approves subcutaneous administration of Takeda’s ENTYVIO (vedolizumab) for maintenance therapy in moderately to severely active Crohn’s Disease
Published: April 19, 2024 by Business Wire
Health Canada approves Merck & Co's KEYTRUDA in combination with chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma treatment following successful Phase 3 trial
Published: April 19, 2024 by EquityBites
High demand for injectable weight-loss drugs has led to supply issues, with most varieties listed in short supply by the FDA; Eli Lilly reports shortages of its Zepbound and Mounjaro could last until 2025
Published: April 19, 2024 by CBS - 12 WJTV (Jackson, MS)

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count